查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1712355

2025年軟骨退化全球市場報告

Cartilage Degeneration Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年軟骨退化市場規模將強勁成長。到 2029 年，這一數字將成長至 166.2 億美元，複合年成長率為 5.5%。預測期內的成長歸因於再生醫學、生物注射、組織工程解決方案、精準醫療和機器人輔助手術的進步。預測期內的關鍵趨勢包括幹細胞療法、整形外科3D 列印、軟骨修復基因療法、個人化復健計劃以及後續觀察的遠端醫療。

預計未來幾年肥胖率的上升將推動軟骨退化市場的成長。肥胖是一種以體內脂肪過度堆積為特徵的疾病，會對健康造成嚴重危害。肥胖會增加軟骨的壓縮力並促進發炎細胞激素的產生，導致軟骨退化。這種疾病會導致膝關節出現多種病理變化，包括關節負荷異常、關節錯位和肌肉無力。例如，英國政府數位服務部門的數據顯示，2021-2022年，18歲以上成年人的超重或肥胖比例為63.8%，高於前一年的63.3%。此外，2020-2021年成人肥胖率從25.2%上升至25.9%。這些統計數據凸顯了肥胖日益成長的影響，刺激了軟骨退化市場的擴張。

老年人口的增加也推動了軟骨退化市場的成長。 65歲及以上的人會出現肌肉和骨骼質量的損失，導致肌肉力量和關節功能下降。軟骨退化治療在減輕與老齡化相關的肌肉骨骼系統變化、強化骨骼和減緩骨質流失方面發揮著重要作用。根據世界衛生組織 (WHO) 的數據，全球 60 歲及以上人口預計將從 2020 年的 10 億增加到 2030 年的 14 億，到 2050 年將增至 21 億。此外，80 歲及以上人口預計將從 2020 年的 1.43 億增加兩倍，到 2050 年將增至 4.26 億。這一人口趨勢是軟骨退化市場的主要驅動力。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球軟骨退化市場 PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素、限制因素）
  • 最終用途產業分析
  • 全球軟骨退化市場：成長率分析
  • 全球軟骨退化市場表現：規模與成長，2019-2024
  • 全球軟骨退化市場預測：2024-2029 年及 2034 年規模與成長
  • 全球軟骨退化總目標市場（TAM）

第6章市場區隔

  • 全球軟骨退化市場（依治療程序、表現及預測）2019-2024、2024-2029、2034
  • 關節重建手術
  • 軟骨成形術
  • 骨軟骨移植
  • 微骨折
  • 半月軟骨移植
  • 基於細胞的軟骨表面置換
  • 自體軟骨細胞移植術
  • 全球軟骨退化市場的應用、表現及預測（2019-2024、2024-2029、2034）
  • 膝關節
  • 髖關節
  • 其他
  • 全球軟骨退化市場（依最終用戶、績效及預測）2019-2024、2024-2029、2034
  • 醫院和專科診所
  • 門診手術中心
  • 學術研究所
  • 全球關節重建退化市場：關節置換按類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 膝關節關節重建（局部、全部）
  • 髖關節置換術（部分和全部）
  • 肩關節關節重建（全肩關節置換術、逆肩關節置換術）
  • 其他關節（踝關節、肘關節、腕關節）
  • 全球軟骨退化市場：軟骨成形術細分市場（按類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 射頻消融軟骨成形術
  • 機械軟骨成形術
  • 熱軟骨成形術
  • 關節鏡成形術
  • 全球軟骨退化市場：骨軟骨移植細分（按類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 自體移植（OATS）
  • 同種異體移植（新鮮骨軟骨同種異體移植）
  • 合成植入
  • 全球軟骨退化市場：微骨折細分（按類型、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 傳統微骨折
  • 增強微骨折
  • 全球軟骨退化市場：半月軟骨植入物細分（按類型、性能及預測），2019-2024 年、2024-2029 年、2034 年
  • 同種異體半月軟骨移植
  • 合成半月軟骨植入
  • 全球軟骨再生市場：基於細胞的軟骨再生細分（按類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 自體細胞療法
  • 同種異體細胞治療
  • 利用幹細胞修復軟骨
  • 全球軟骨退化市場：自體軟骨細胞移植術（ACI）細分市場（按類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 第一代ACI
  • 第二代ACI
  • 第三代ACI（MACI）
  • 全球軟骨退化市場：其他細分市場：按類型、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 關節鏡創術
  • 截骨術
  • 使用合成支架修復軟骨
  • 注射治療方法

第7章 區域和國家分析

  • 全球軟骨退化市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球軟骨退化市場：依國家、地區、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 軟骨退化市場：競爭格局
  • 軟骨退化市場：公司簡介
    • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • MEDIPOST Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Smith and Nephew plc
  • B Braun Melsungen AG
  • Osiris Therapeutics Inc.
  • Arthrex Inc.
  • Conmed Corporation
  • Orthocell Ltd.
  • Bioventus LLC
  • Aesculap Inc.
  • Vericel Corporation
  • Anika Therapeutics Inc.
  • Geistlich Pharma AG
  • MatTek Corporation
  • Breg Inc.
  • Isto Biologics Inc.
  • OrthoTrophix LLC

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029 年軟骨退化市場：提供新機會的國家
  • 2029 年軟骨退化市場：細分領域帶來新機會
  • 2029 年軟骨退化市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r32444

Cartilage degeneration refers to the progressive deterioration or breakdown of cartilage, a smooth and flexible connective tissue that covers the ends of bones in joints. This tissue acts as a cushion, enabling smooth joint movement by minimizing friction between bones. The degeneration of cartilage can result in pain, stiffness, and reduced joint functionality.

Common procedures to address cartilage degeneration include joint replacements, chondroplasty, osteochondral transplants, microfracture, meniscus transplants, cell-based cartilage resurfacing, and autologous chondrocyte implantation. Joint replacements involve surgically replacing a damaged or diseased joint with an artificial prosthesis. These procedures are applied to various joints such as the knee and hip and are performed in settings like hospitals, specialty clinics, ambulatory surgical centers, and academic or research institutes.

The cartilage degeneration market research report is one of a series of new reports from The Business Research Company that provides cartilage degeneration market statistics, including cartilage degeneration industry global market size, regional shares, competitors with a cartilage degeneration market share, detailed cartilage degeneration market segments, market trends and opportunities, and any further data you may need to thrive in the cartilage degeneration industry. This cartilage degeneration market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cartilage degeneration market size has grown strongly in recent years. It will grow from $12.63 billion in 2024 to $13.4 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to aging population, joint injuries, obesity epidemic, sports injuries, limited self-repair capacity.

The cartilage degeneration market size is expected to see strong growth in the next few years. It will grow to $16.62 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to regenerative medicine advancements, biologic injections, tissue engineering solutions, precision medicine, robotics-assisted surgery. Major trends in the forecast period include stem cell therapies, 3D printing in orthopedics, gene therapy for cartilage repair, personalized rehabilitation programs, telemedicine for follow-up care.

The rising prevalence of obesity is expected to drive the growth of the cartilage degeneration market in the coming years. Obesity, a condition characterized by excessive body fat accumulation, poses significant health risks. It contributes to cartilage degeneration by increasing compressive forces on cartilage and promoting inflammatory cytokines. This condition leads to several pathological changes in the knee joint, such as abnormal joint loading, misalignment, and muscle weakness. For example, data from the Government Digital Service in the UK revealed that in 2021-2022, 63.8% of adults aged 18 and older were classified as overweight or obese, up from 63.3% the previous year. Additionally, the obesity rate among adults increased from 25.2% in 2020-2021 to 25.9%. These statistics highlight the growing impact of obesity, which is fueling the expansion of the cartilage degeneration market.

The growth of the cartilage degeneration market is also being propelled by the increasing elderly population. Individuals aged 65 and older experience muscle and bone mass loss, leading to reduced strength and joint functionality. Cartilage degeneration treatments play a vital role in mitigating age-related changes in the musculoskeletal system, strengthening bones, and slowing bone loss. According to the World Health Organization (WHO), the global population aged 60 and older is projected to rise from 1 billion in 2020 to 1.4 billion by 2030, and 2.1 billion by 2050. Furthermore, the population aged 80 and older is expected to triple from 143 million in 2020 to 426 million by 2050. This demographic trend is a key driver of the cartilage degeneration market.

Leading companies in the cartilage degeneration market are innovating products to enhance cartilage repair and regeneration. One such product is Agili-C, a cell-free implant used to treat cartilage and osteochondral defects in traumatic and osteoarthritic joints. In July 2023, CartiHeal Ltd., an Israeli medical device company, announced the first commercial implantation of Agili-C. Made from natural calcium carbonate derived from coral exoskeletons, the implant stimulates chondrocyte migration and extracellular matrix deposition. This design promotes natural cartilage and bone regeneration without relying on cells or growth factors. The implant's approval reinforces its safety and efficacy, benefiting patients and healthcare providers.

Companies in the cartilage degeneration market are increasingly focusing on regenerative therapies to strengthen their market positions. These therapies leverage advanced biological methods to restore damaged cartilage, promoting natural healing. For instance, in 2023, Zimmer Biomet, a U.S.-based medical device company, introduced its Tissue Regeneration System. This system employs proprietary scaffold technology made of biocompatible materials to support cartilage repair. It also offers customizable options to meet individual patient needs, improving healing outcomes and recovery times. Such innovations highlight a shift toward personalized medicine, addressing osteoarthritis and sports injuries while enhancing patient satisfaction.

In July 2022, Bioventus Inc., a U.S.-based company specializing in active healing and surgical orthobiologics, acquired CartiHeal for $315 million. This acquisition aims to bolster Bioventus' joint preservation technologies, contributing to its growth strategy and supporting its goal of sustained double-digit revenue growth. CartiHeal Ltd. develops proprietary implants for treating cartilage and osteochondral defects in traumatic and osteoarthritic joints, further enriching Bioventus' portfolio.

Major companies operating in the cartilage degeneration market report are Johnson & Johnson Services Inc., MEDIPOST Co. Ltd., Medtronic PLC, Stryker Corporation, Zimmer Biomet Holdings Inc., Smith and Nephew PLC, B Braun Melsungen AG, Osiris Therapeutics Inc., Arthrex Inc., Conmed Corporation, Orthocell Ltd., Bioventus LLC, Aesculap Inc., Vericel Corporation, Anika Therapeutics Inc., Geistlich Pharma AG, MatTek Corporation, Breg Inc., Isto Biologics Inc., OrthoTrophix LLC, CellGenix GmbH, CartiHeal Inc., Cayenne Medical Inc., Collagen Solutions PLC, Regentis Biomaterials Ltd., Histogen Inc., BioTime Inc., CollPlant Holdings Ltd.

North America was the largest region in the cartilage degeneration market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cartilage degeneration market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the cartilage degeneration market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The cartilage degeneration market consists of revenues earned by entities by provide services such as diagnosis and evaluation, non-surgical management, patient education, physical therapy, and nutritional and lifestyle guidance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cartilage degeneration market also includes sales of over-the-counter medications, joint supplements, topical pain relievers, and hyaluronic acid injections. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cartilage Degeneration Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cartilage degeneration market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cartilage degeneration ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cartilage degeneration market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Procedure: Joint Replacements; Chondroplasty; Osteochondral Transplants; Microfracture; Meniscus Transplants; Cell-Based Cartilage Resurfacing; Autologous Chondrocyte Implantation; Other Procedures
  • 2) By Application: Knee; Hip; Other Applications
  • 3) By End User: Hospitals And Specialty Clinics; Ambulatory Surgical Centers; Academic And Research Institutes
  • Subsegments:
  • 1) By Joint Replacements: Knee Replacement (Partial, Total); Hip Replacement (Partial, Total); Shoulder Replacement (Total, Reverse); Other Joints (Ankle, Elbow, Wrist)
  • 2) By Chondroplasty: Radiofrequency Ablation Chondroplasty; Mechanical Chondroplasty; Thermal Chondroplasty; Arthroscopic Chondroplasty
  • 3) By Osteochondral Transplants: Autografts (OATS); Allografts (Fresh Osteochondral Allografts); Synthetic Implants
  • 4) By Microfracture: Traditional Microfracture; Augmented Microfracture (with scaffolds or matrix implants)
  • 5) By Meniscus Transplants: Allograft Meniscus Transplantation (Cryopreserved, Fresh Frozen); Synthetic Meniscus Implants
  • 6) By Cell-Based Cartilage Resurfacing: Autologous Cell-Based Therapy; Allogeneic Cell-Based Therapy; Stem Cell-Based Cartilage Repair
  • 7) By Autologous Chondrocyte Implantation (ACI): First-Generation ACI; Second-Generation ACI; Third-Generation ACI (MACI)
  • 8) By Other Procedures: Arthroscopic Debridement; Osteotomy; Cartilage Repair Using Synthetic Scaffolds; Injection-Based Therapies (Hyaluronic Acid, PRP, Stem Cell Injections)
  • Companies Mentioned: Johnson & Johnson Services Inc.; MEDIPOST Co. Ltd.; Medtronic plc; Stryker Corporation; Zimmer Biomet Holdings Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cartilage Degeneration Market Characteristics

3. Cartilage Degeneration Market Trends And Strategies

4. Cartilage Degeneration Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Cartilage Degeneration Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Cartilage Degeneration PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Cartilage Degeneration Market Growth Rate Analysis
  • 5.4. Global Cartilage Degeneration Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Cartilage Degeneration Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Cartilage Degeneration Total Addressable Market (TAM)

6. Cartilage Degeneration Market Segmentation

  • 6.1. Global Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Joint Replacements
  • Chondroplasty
  • Osteochondral Transplants
  • Microfracture
  • Meniscus Transplants
  • Cell-Based Cartilage Resurfacing
  • Autologous
  • 6.2. Global Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Knee
  • Hip
  • Other Applications
  • 6.3. Global Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Specialty Clinics
  • Ambulatory Surgical Centers
  • Academic And Research Institutes
  • 6.4. Global Cartilage Degeneration Market, Sub-Segmentation Of Joint Replacements, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Knee Replacement (Partial, Total)
  • Hip Replacement (Partial, Total)
  • Shoulder Replacement (Total, Reverse)
  • Other Joints (Ankle, Elbow, Wrist)
  • 6.5. Global Cartilage Degeneration Market, Sub-Segmentation Of Chondroplasty, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Radiofrequency Ablation Chondroplasty
  • Mechanical Chondroplasty
  • Thermal Chondroplasty
  • Arthroscopic Chondroplasty
  • 6.6. Global Cartilage Degeneration Market, Sub-Segmentation Of Osteochondral Transplants, B Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Autografts (OATS)
  • Allografts (Fresh Osteochondral Allografts)
  • Synthetic Implants
  • 6.7. Global Cartilage Degeneration Market, Sub-Segmentation Of Microfracture, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Traditional Microfracture
  • Augmented Microfracture
  • 6.8. Global Cartilage Degeneration Market, Sub-Segmentation Of Meniscus Transplants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Allograft Meniscus Transplantation
  • Synthetic Meniscus Implants
  • 6.9. Global Cartilage Degeneration Market, Sub-Segmentation Of Cell-Based Cartilage Resurfacing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Autologous Cell-Based Therapy
  • Allogeneic Cell-Based Therapy
  • Stem Cell-Based Cartilage Repair
  • 6.10. Global Cartilage Degeneration Market, Sub-Segmentation Of Autologous Chondrocyte Implantation (ACI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • First-Generation ACI
  • Second-Generation ACI
  • Third-Generation ACI (MACI)
  • 6.11. Global Cartilage Degeneration Market, Sub-Segmentation Of Other Procedures, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Arthroscopic Debridement
  • Osteotomy
  • Cartilage Repair Using Synthetic Scaffolds
  • Injection-Based Therapies

7. Cartilage Degeneration Market Regional And Country Analysis

  • 7.1. Global Cartilage Degeneration Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Cartilage Degeneration Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cartilage Degeneration Market

  • 8.1. Asia-Pacific Cartilage Degeneration Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cartilage Degeneration Market

  • 9.1. China Cartilage Degeneration Market Overview
  • 9.2. China Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cartilage Degeneration Market

  • 10.1. India Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cartilage Degeneration Market

  • 11.1. Japan Cartilage Degeneration Market Overview
  • 11.2. Japan Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cartilage Degeneration Market

  • 12.1. Australia Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cartilage Degeneration Market

  • 13.1. Indonesia Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cartilage Degeneration Market

  • 14.1. South Korea Cartilage Degeneration Market Overview
  • 14.2. South Korea Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cartilage Degeneration Market

  • 15.1. Western Europe Cartilage Degeneration Market Overview
  • 15.2. Western Europe Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cartilage Degeneration Market

  • 16.1. UK Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cartilage Degeneration Market

  • 17.1. Germany Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cartilage Degeneration Market

  • 18.1. France Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cartilage Degeneration Market

  • 19.1. Italy Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cartilage Degeneration Market

  • 20.1. Spain Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cartilage Degeneration Market

  • 21.1. Eastern Europe Cartilage Degeneration Market Overview
  • 21.2. Eastern Europe Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cartilage Degeneration Market

  • 22.1. Russia Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cartilage Degeneration Market

  • 23.1. North America Cartilage Degeneration Market Overview
  • 23.2. North America Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cartilage Degeneration Market

  • 24.1. USA Cartilage Degeneration Market Overview
  • 24.2. USA Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cartilage Degeneration Market

  • 25.1. Canada Cartilage Degeneration Market Overview
  • 25.2. Canada Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cartilage Degeneration Market

  • 26.1. South America Cartilage Degeneration Market Overview
  • 26.2. South America Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cartilage Degeneration Market

  • 27.1. Brazil Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cartilage Degeneration Market

  • 28.1. Middle East Cartilage Degeneration Market Overview
  • 28.2. Middle East Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cartilage Degeneration Market

  • 29.1. Africa Cartilage Degeneration Market Overview
  • 29.2. Africa Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cartilage Degeneration Market Competitive Landscape And Company Profiles

  • 30.1. Cartilage Degeneration Market Competitive Landscape
  • 30.2. Cartilage Degeneration Market Company Profiles
    • 30.2.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. MEDIPOST Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Cartilage Degeneration Market Other Major And Innovative Companies

  • 31.1. Smith and Nephew plc
  • 31.2. B Braun Melsungen AG
  • 31.3. Osiris Therapeutics Inc.
  • 31.4. Arthrex Inc.
  • 31.5. Conmed Corporation
  • 31.6. Orthocell Ltd.
  • 31.7. Bioventus LLC
  • 31.8. Aesculap Inc.
  • 31.9. Vericel Corporation
  • 31.10. Anika Therapeutics Inc.
  • 31.11. Geistlich Pharma AG
  • 31.12. MatTek Corporation
  • 31.13. Breg Inc.
  • 31.14. Isto Biologics Inc.
  • 31.15. OrthoTrophix LLC

32. Global Cartilage Degeneration Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cartilage Degeneration Market

34. Recent Developments In The Cartilage Degeneration Market

35. Cartilage Degeneration Market High Potential Countries, Segments and Strategies

  • 35.1 Cartilage Degeneration Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Cartilage Degeneration Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Cartilage Degeneration Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer